Averica Announces Winner for First Award

mia.burns Averica Discovery Announces Winner of First Averica Award for Supercritical Fluid Chromatography (SFC) — Pfizer’s Bill Farrell Honored for Contributions to Preparative ...

Repros Announces Formation of Androxal Clinical and Commercial Advisory Board

barbara.lempert 13 Leading KOL’s Join Newly Formed Advisory Board THE WOODLANDS, Texas, July 9, 2013 (GLOBE NEWSWIRE) — Repros Therapeutics Inc.(R) (Nasdaq:RPRX) today ...

Astex Pharmaceuticals Announces IND Candidate: ASTX727

barbara.lempert  Astex Pharmaceuticals Announces IND Candidate: ASTX727 a Potential Best-in-Class Oral Hypomethylator Investigational New Drug (IND) Application and Data Presentations ...

Blackfield Announces Fourth Major Pharmaceutical Company Collaboration

barbara.lempert Cologne, Germany, July 9, 2013 / B3C newswire / – Blackfield announced today that it has entered a collaboration with AstraZeneca, a global biopharmaceutical ...

Depomed Announces Appointment of Louis J. Lavigne, Jr. to Board of Directors

barbara.lempert NEWARK, Calif., July 8, 2013 /PRNewswire/ — Depomed, Inc. (NASDAQ: DEPO) today announced the appointment of Louis J. Lavigne, Jr. to the company’s Board ...

ULURU Inc. Announces Expansion Of The Altrazeal International Marketing Network

barbara.lempert ADDISON, Texas, July 8, 2013 /PRNewswire/ — ULURU Inc. (OTCQB: ULUR) today announced the expansion of the Altrazeal® international marketing network to include ...

Soligenix Announces Commercial Collaboration with SciClone Pharmaceuticals in China

barbara.lempert Soligenix Announces Commercial Collaboration with SciClone Pharmaceuticals in China for SGX942 in the Treatment of Oral Mucositis Access to SciClone Oral Mucositis ...

Convergence Pharmaceuticals Announces Start of Phase II Study for Cav2.2 Selective Blocker, CNV2197944

barbara.lempert Convergence Pharmaceuticals Announces Start of Phase II Study for Cav2.2 Selective Blocker, CNV2197944 in Pain Associated with Diabetic Peripheral Neuropathy (DPN) CAMBRIDGE, ...

Prosensa Holding N.V. Announces Closing of Initial Public Offering

barbara.lempert Leiden, the Netherlands—July 8, 2013—Prosensa Holding N.V. (“Prosensa”) announced today the closing of its previously announced initial public offering of 6,900,000 ...

Lilly Announces Dr. Lechleiter’s Return

barbara.lempert INDIANAPOLIS, July 8, 2013 /PRNewswire/ — Eli Lilly and Company (NYSE:LLY) today announced that John C. Lechleiter, Ph.D., has returned to his duties ...

Nanobiotix announces €2.8 million grant from bpifrance to accelerate development of NBTXR3 in a third new indication

barbara.lempert Through ETPN (European Technology Platform of Nanomedicine), Nanobiotix is driving nanomedicine in Europe and is now involved in the first nanomedicine consortium in ...

Intellipharmaceutics Announces Second Quarter 2013 Results

barbara.lempert TORONTO, July 2, 2013 (GLOBE NEWSWIRE) — Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, ...
Page 5 of 12« First...34567...10...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS